hexamethylene bisacetamide has been researched along with baicalin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, K; Guo, Q; Jiang, G; Jiang, Z; Li, C; Ren, X; Song, G; Wang, H; Zhang, Y; Zhang, Z | 1 |
1 other study(ies) available for hexamethylene bisacetamide and baicalin
| Article | Year |
|---|---|
Enhancement of baicalin by hexamethylene bisacetamide on the induction of apoptosis contributes to simultaneous activation of the intrinsic and extrinsic apoptotic pathways in human leukemia cells.
Topics: Acetamides; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Caspase 8; Caspase 9; Cell Line, Tumor; Flavonoids; G1 Phase; Healthy Volunteers; Humans; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear | 2013 |